Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome

Health Technology Assessment

Volumn 17, Issue 1, 2013, Pages 1-210

  Goodacre, S ^a   Thokala, P ^a   Carroll, C ^a   Stevens, J W ^a   Leaviss, J ^a   Al Khalaf, M ^a   Collinson, P ^a   Morris, F ^a   Evans, P ^a   Wang, J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; MYELOPEROXIDASE; TROPONIN;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ARTICLE; CITATION ANALYSIS; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ECONOMIC ASPECT; ECONOMIC EVALUATION; EXERCISE ELECTROCARDIOGRAPHY; HEART INFARCTION; HUMAN; META ANALYSIS; PREDICTIVE VALUE; PROGNOSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ACUTE CORONARY SYNDROME; BAYES THEOREM; BIOLOGICAL MARKERS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ELECTROCARDIOGRAPHY; EXERCISE TEST; FATTY ACID-BINDING PROTEINS; HUMANS; MODELS, ECONOMETRIC; MYOCARDIAL INFARCTION; MYOGLOBIN; PROGNOSIS; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; TROPONIN T;

EID: 84872921192     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta17010     Document Type: Article

References (175)

1. Department of Health (DoH). The National Service Framework for Coronary Heart Disease. London: DoH; 2000.
2. Goldberg RJ, Currie K, White K, Brieger D, Steg PG, Goodman SG, et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2004;93:288-93.
3. Goodacre S, Cross E, Arnold J, Angelini K, Capewell S, Nicholl J. The health care burden of acute chest pain. Heart 2005;91:229-30.
4. The NHS Health and Social Care Information Centre. Hospital Episodes Statistics for England, 1998-2010. 2011. URL: www.hesonline.nhs.uk/.
5. Walker L, Weston C, Birkhead J, van Leeven R, Dodd S, Dancy M, et al. Myocardial Infarction National Audit Project, 9th Public Report: How the NHS manages heart attacks. London: Royal College of Physicians; 2010.
6. Blunt I, Bardsley M, Dixon J. Trends in emergency admissions in England 2004-2009: is greater efficiency breeding inefficiency? London: The Nuffeld Trust; 2010.
7. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.
8. Ebell MH, White LL, Weismantel D, Ebell MH, White LL, Weismantel D. A systematic review of troponin T and I values as a prognostic tool for patients with chest pain. J Fam Pract 2000;49:746-53.
9. Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med 1999;340:1623-9.
10. Ebell MH, Flewelling D, Flynn CA. A systematic review of troponin T and I for diagnosing acute myocardial infarction. J Fam Pract 2000;49:550-6.
11. Cooper A, Calvert N, Skinner J, Sawyer L, Sparrow K, Timmis A, et al. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. Clinical Guideline 95. London: National Clinical Guideline Centre for Acute and Chronic Conditions; 2010.
12. Goodacre S, Bradburn M, Cross E, Fitzgerald P, Collinson P, Gray A, et al. The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac Markers Trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Health Technol Assess 2011;15(23).
13. Cross E, How S, Goodacre S. Development of acute chest pain services in the UK. Emerg Med J 2007;24:100-2.
14. Camm J, Gray H, Antoniou S, Cadman J, Crowe E, de Belder M, et al. Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction. Clinical Guideline 94. London; National Clinical Guideline Centre; 2010.
15. Erhardt L, Herlitz J, Bossaert L, Halinen M, Keltai M, Koster R, et al. Task force on the management of chest pain. Eur Heart J 2002;23:1153-76.
16. Dunham M, Challen K, Walter D. Risk stratification of patients with acute chest pain without a rise in troponin: current practice in England. Emerg Med J 2010;27:461-4.
17. Collinson PO, Stubbs PJ, Kessler A. Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice. Heart 2003;89:280-6.
18. Eggers KM, Oldgren J, ld A, Lindahl B, Eggers KM, Oldgren J, et al. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004;148:574-81.
19. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;27;361, 858-67.
20. Keller TZ. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
21. Balk EM, I. Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: A meta-analysis. Ann Emerg Med 2001;37:478-94.
22. Mitchell AM, Brown MD, Menown IBA, Kline JA. Novel protein markers of acute coronary syndrome complications in low-risk outpatients: A systematic review of potential use in the emergency department. Clin Chem 2005;51:2005-11.
23. Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess 2009;13(32).
24. Goodacre S, Cross E, Lewis C, Capewell S, on behalf of the ESCAPE Research Team. The ESCAPE cluster randomised trial: Effectiveness and Safety of Chest pain Assessment to Prevent Emergency admissions. BMJ 2007;335:659-62.
25. Mowatt G, Cummins E, Waugh N, Walker S, Cook J, Jia X, et al. Systematic review of the clinical effectiveness and cost-effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of coronary artery disease. Health Technol Assess 2008;12(17).
26. Centre for Review and Dissemination (CRD). CRD's guidance for undertaking reviews in health care. York: CRD, University of York; 2008.
27. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. In Deeks JJ, Bossuyt PM, Gatsonis C (editors). Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration; 2010. URL: http://srdta. cochrane.org/
28. Whiting P, Rutjes AWS, Reitsma JB, Bossuyt PMM, Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 2004;8(25).
29. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ 2001;323:224-8.
30. Sutton A, Cooper N, Goodacre S, Stevenson M. Integration of meta-analysis and economic decision modelling for evaluating diagnostic tests. Med Dec Making 2008;28:650-68.
31. Ades A, Lu G, Higgins JPT. The interpretation of random effects meta-analyses in decision models. Med Dec Making 2005;25:646-54.
32. Spiegelhalter DJ, Abrams KR, Myles J P. Bayesian approaches to clinical trials and health-care evaluation. London: John Wiley & Sons; 2004.
33. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS: a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 2000;10:325-37.
34. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med 2002;21:1601-23.
35. Brooks S.P GA. Alternative methods for monitoring convergence of iterative simulations. J Comput Graph Stat 1998;7:434-45.
36. Alhashemi JA. Diagnostic accuracy of a bedside qualitative immunochromatographic test for acute myocardial infarction. Am J Emerg Med 2006;24:149-55.
37. Eggers KM, Ellenius J, Dellborg M, Groth T, Oldgren J, Swahn E, et al. Artificial neural network algorithms for early diagnosis of acute myocardial infarction and prediction of infarct size in chest pain patients. Int J Cardiol 2007;114:366-74.
38. Kurz K. Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome. Clin Res Cardiol 2011;100:209-15.
39. Macdonald S P, Nagree Y, Macdonald SPJ, Nagree Y. Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: a pilot study. Emerg Med Australas 2008;20:403-9.
40. Ooi S. Incremental value of heart-type fatty acid-binding protein, myoglobin, troponin T and electrocardiogram in rapid bedside diagnosis of acute coronary syndrome in chest pain patients presenting to the emergency department. Society for Academic Emergency Medicine Annual Meeting 2007. Acad Emerg Med 2007;14:S131.
41. Rathore S, Knowles P, Mann A P, Dodds PA, Rathore S, Knowles P, et al. Is it safe to discharge patients from accident and emergency using a rapid point of care Triple Cardiac Marker test to rule out acute coronary syndrome in low to intermediate risk patients presenting with chest pain? Eur J Intern Med 2008;19:537-40.
42. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski J. Role of 'Ischemia Modified Albumin', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34.
43. Eggers KM, Oldgren J, ld A, Lindahl B, Eggers KM, Oldgren J, et al. Combining different biochemical markers of myocardial ischemia does not improve risk stratification in chest pain patients compared to troponin I alone. Coron Artery Dis 2005;16:315-19.
44. Eggers KM, Kempf T, Venge P, Wallentin L, Wollert KC, Lindahl B, et al. Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected non-necrosis biomarkers. Am Heart J 2010;160:88-94.
45. Mockel M, Muller R, Vollert JO, Muller C, Danne O, Gareis R, et al. Lipoprotein-associated phospholipase A for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach. Clin Res Cardiol 2007;96:604-12.
46. Body R, Phil P. Low soluble P-selection may facilitate early exclusion of acute myocardial infarction. Clin Chim Acta 2011;412:614-18.
47. Brown AM, Wu AH, Clopton. ST2 in emergency department chest pain patients with potential acute coronary syndromes. Ann Emerg Med 2007;50:153-8.
48. Collinson PO, Gaze DC, Bainbridge K, Morris F, Morris B, Price A, et al. Utility of admission cardiac troponin and 'ischemia Modified albumin' measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 2006;23:256-61.
49. Garcia-Valdecasas S, Ruiz-Alvarez MJ, Garcia DT, De Pablo. Diagnostic and prognostic value of heart-type fatty acid-binding protein in the early hours of acute myocardial infarction. Acta Cardiol 2011;66:315-21.
50. Ilva T, Lund J, Porela P, Mustonen H, Voipio-Pulkki LM, Eriksson S, et al. Early markers of myocardial injury: cTnI is enough. Clin Chim Acta 2009;400:82-5.
51. Potsch AA, Siqueira Filho AG, Tura BR, Gamarski R, Bassan R, Nogueira MV, et al. C-reactive protein diagnostic and prognostic value in patients presenting at the emergency room with chest pain. Arq Bras Cardiol 2006;87:275-80.
52. Amodio G, Antonelli G, Varraso L, Ruggieri V, Di S F, Amodio G, et al. Clinical impact of the troponin 99th percentile cut-off and clinical utility of myoglobin measurement in the early management of chest pain patients admitted to the Emergency Cardiology Department. Coron Artery Dis 2007;18:181-6.
53. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM, Benoit MO, et al. Use of the bioMerieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chim Acta 2008;390:72-5.
54. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM. Use of the centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008;54:723-8.
55. Apple FS, Smith SW, Pearce LA, Murakami MM, Apple FS, Smith SW, et al. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2009;55:93-100.
56. Bassan R, Potsch A, Maisel A, Tura B, Villacorta H, Nogueira MV, et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005;26:234-40.
57. Body R, McDowell H, Carley S, Wibberley C, Ferguson J, Mackway-Jones K. A FABP-ulous 'rule out' strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction. Resuscitation 2011;82:1041-6.
58. Cete YE. The value of point-of-care fatty acid binding protein in patients with chest pain in determining myocardial infarction in the emergency setting. Hong Kong J Emerg Med 2010;17:224-9.
59. Charpentier S, Ducasse JL, Cournot M, Maupas-Schwalm F, Elbaz M, Baixas C, et al. Clinical assessment of ischemia-Modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department. Acad Emerg Med 2010;17:27-35.
60. Christ M, Popp S, Pohlmann H, Poravas M, Umarov D, Bach R, et al. Implementation of High Sensitivity Cardiac Troponin T Measurement in the Emergency Department. Am J Med 2010;123:1134-42.
61. Christenson RH, Duh SH, Sanhai WR, Wu AHB, Holtman V, Painter P, et al. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464-70.
62. Collinson PO, Gaze DC, Stubbs PJ, Swinburn J, Khan M, Senior R, et al. Diagnostic and prognostic role of cardiac troponin I (cTnI) measured on the DPC Immulite. Clin Biochem 2006;39:692-6.
63. Di Serio F, Amodio G, Ruggieri E, De Sario R, Varraso L, Antonelli G, et al. Proteomic approach to the diagnosis of acute coronary syndrome: preliminary results. Clin Chim Acta 2005;357:226-35.
64. Ecollan P, Collet J P, Boon G, Tanguy ML, Fievet ML, Haas R, et al. Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay. Int J Cardiol 2007;119:349-54.
65. Esporcatte R, Rey HC, Rangel FO, Rocha RM, Filho H T, Dohmann H F, et al. Predictive value of myeloperoxidase to identify high risk patients admitted to the hospital with acute chest pain. Arq Bras Cardiol 2007;89:377-84.
66. Guo X F. The predictive value of the bedside troponin T test for patients with acute chest pain. Exp Clin Cardiol 2006;11:298-301.
67. Haltern G, Peiniger S, Bufe A, Reiss G, lker H, Scheffold T. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. Am J Cardiol 2010;105:1-9.
68. Hjortshoj S, Kristensen SR, Ravkilde J. Diagnostic value of ischemia-Modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med 2010;28:170-6.
69. Ilva T, Eriksson S, Lund J, Porela P, Mustonen H, Pettersson K, et al. Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept. Eur J Clin Invest 2005;35:112-16.
70. Keating L, Benger JR, Beetham R, Bateman S, Veysey S, Kendall J, et al. The PRIMA study: presentation ischaemia-Modified albumin in the emergency department. Emerg Med J 2006;23:764-8.
71. Keller T, Tzikas S, Zeller T, Czyz E, Lillpopp L, Ojeda FM, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010;55:2096-106.
72. Lefevre G F. Multicenter evaluation of h-FABP semi-quantitative assay (Cardio Detect in central laboratory: the point in acute myocardial infarction diagnosis. Ann Biol Clin 2007;65:377-84.
73. Li C, Li J, Liang X, Li X, Cui J, Yang Z, et al. Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction. Acta Pharmacol Sin 2010;31:307-12.
74. Liao J, Chan C P, Cheung YC, Lu JH, Luo Y, Cautherley GW, et al. Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction. Int J Cardiol 2009;133:420-3.
75. Mad P, Domanovits H, Fazelnia C, Stiassny K, ller G, Cseh A, et al. Human heart-type fatty-acid- binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM 2007;100:203-10.
76. McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 2008;29:2843-50.
77. Mion MM, Novello E, Altinier S, Rocco S, Zaninotto M, Plebani M, et al. Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology. Clin Biochem 2007;40:1245-51.
78. Naroo GYM. Elevated heart-type fatty acid-binding protein predicts early myocardial injury and aids in the diagnosis of non-ST elevation myocardial infarction. Hong Kong J Emerg Med 2009;16:141-7.
79. Penttilä K, Koukkunen H, Halinen M, Rantanen T, Pyörälä K, et al. Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain. Clin Biochem 2002;35:647-53.
80. Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009;54:60-8.
81. Rudolf V, Goldmann BU, Bös C, Rudolph TK, Klinke A, Friedrichs K, et al. Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction. Int J Cardiol 2011;153:267-71.
82. Valle HA, Riesgo LG, Bel MS, Gonzalo FE, Sanchez MS, Oliva LI, et al. Clinical assessment of heart- type fatty acid binding protein in early diagnosis of acute coronary syndrome. Eur J Emerg Med 2008;15:140-4.
83. Venge P, Johnston N, Lindahl B, James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009;54:1165-72.
84. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-65.
85. Eggers KM, Dellborg M, Oldgren J, Swahn E, Venge P, Lindahl B, et al. Risk prediction in chest pain patients by biochemical markers including estimates of renal function. Int J Cardiol 2008;128:207-13.
86. Mockel MD. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin Chim Acta 2008;393:103-9.
87. Apple FS, Pearce LA, Chung A, Ler R, Murakami MM, Apple FS, et al. Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2007;53:874-81.
88. Apple FS, Smith SW, Pearce LA, Schulz KM, Ler R, Murakami MAM, et al. Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations. Clin Chem 2011;57:603-8.
89. Bholasingh R, Cornel JH, Kamp O, Van Straalen J P, Sanders GT, Dijksman L, et al. The prognostic value of markers of infammation in patients with troponin T-negative chest pain before discharge from the emergency department. Am J Med 2003;115:521-8.
90. Blum AS. The prognostic value of high-sensitive C-reactive protein and cardiac troponin T in young and middle-aged patients with chest pain without ECG changes. Eur J Intern Med 2003;14:310-14.
91. Brennan ML, Penn MS, Van LF, Nambi V, Shishehbor MH, Aviles RJ, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349:1595-604.
92. Brown AM, Sease KL, Robey JL, Shofer FS, Hollander JE. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome. Ann Emerg Med 2007;49:153-63.
93. Brugger-Andersen TP. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: A prognostic study. BMC Cardiovasc Disord 2008;8:34.
94. Cameron SJ, Sokoll LJ, Laterza O F, Shah S, Green GB, Cameron SJ, et al. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes. Clin Chim Acta 2007;376:168-73.
95. Consuegra-Sanchez LB-M. Ischemia-Modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain. Heart Vessels 2008;23:174-80.
96. De Winter RJ, Koster RW, Schotveld JH, Sturk A, Van Straalen J P, Sanders GT, et al. Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction. Heart 1996;75:235-9.
97. Eggers KM, Kempf T, Allhoff T, Lindahl B, Wallentin L, Wollert KC, et al. Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain. Eur Heart J 2008;29:2327-35.
98. Fromm R, Meyer D, Zimmerman J, Boudreaux A, Wun CC, Smalling R, et al. A double-blind, multicentered study comparing the accuracy of diagnostic markers to predict short- and long-term clinical events and their utility in patients presenting with chest pain. Clin Cardiol 2001;24:516-20.
99. Green GB, Skarbek-Borowski GW, Chan DW, Kelen GD, Green GB, Skarbek-Borowski GW, et al. Myoglobin for early risk stratification of emergency department patients with possible myocardial ischemia. Acad Emerg Med 2000;7:625-36.
100. Hillis GS, Taggart P, Hillis L, Zhao N, Dalsey WC, Mangione A, et al. Biochemical and clinical predictors of long-term outcome in patients with nonspecific chest pain and nondiagnostic electrocardiograms. Am Heart J 200;145:88-94.
101. Jaffery Z, Nowak R, Khoury N, Tokarski G, Lanfear DE, Jacobsen G, et al. Myoglobin and troponin I elevation predict 5-year mortality in patients with undifferentiated chest pain in the emergency department. Am Heart J 2008;156:939-45.
102. Jernberg T, Stridsberg M, Venge P, Lindahl B, Jernberg T, Stridsberg M, et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-45.
103. Kavsak PA, Wang XS, Henderson M, Ko DT, MacRae AR, Jaffe AS. PAPP-A as a marker of increased long-term risk in patients with chest pain. Clin Biochem 2009;42:1012-18.
104. Kontos MC, Garg R, Anderson F P, Roberts CS, Ornato J P, Tatum JL, et al. Ability of myoglobin to predict mortality in patients admitted for exclusion of myocardial infarction. Am J Emerg Med 2007;25:873-9.
105. Laterza O F, Cameron SJ, Chappell D, Sokoll LJ, Green GB, Laterza O F, et al. Evaluation of pregnancy- associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clin Chim Acta 2004;348:163-9.
106. Lim J, Hawkins RC, Ng K, Chan S P, Cheng A, Ng KS, et al. A preliminary study of the utility of combined cardiac markers in the evaluation of patients presenting early with suspected acute coronary syndrome. Ann Acad Med Singapore 2002;31:772-6.
107. Lund J, Qin Q, Ilva T, Pettersson K, Voipio-Pulkki L, Porela P, et al. Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003;108:1924-6.
108. Manini A F, Ilgen J, Noble VE, Bamberg F, Koenig W, Bohan JS, et al. Derivation and validation of a sensitive IMA cutpoint to predict cardiac events in patients with chest pain. Emerg Med J 2009;26:791-6.
109. Markovic M, Ignjatovic S, Dajak M, Majkic-Singh N, Markovic M, Ignjatovic S, et al. Utility of placental growth factor for prediction of 30-day adverse event in emergency department population with non-ST elevation acute coronary syndrome. Clin Lab 2010;56:215-22.
110. Mathew T, Menown I, Smith B, Smye M, Nesbitt S, Young I, et al. Diagnosis and risk stratification of patients with anginal pain and non-diagnostic electrocardiograms. QJM 1999;92:565-71.
111. McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, et al. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. Am J Cardiol 2009;103:22-8.
112. McCord J, Nowak RM, Hudson MP, McCullough PA, Tomlanovich MC, Jacobsen G, et al. The prognostic signifcance of serial myoglobin troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome. Ann Emerg Med 2003;42:343-50.
113. Menown IB, Mathew TP, Gracey HM, Nesbitt GS, Murray P, Young IS, et al. Prediction of recurrent events by D-Dimer and inflammatory markers in patients with normal cardiac troponin I (PREDICT). Study. Am Heart J 2003;145:986-92.
114. Newby LK, Storrow AB, Gibler WB, Garvey JL, Tucker J F, Kaplan AL, et al. Beside multimarker testing for risk stratification in chest pain units: the Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) study. Circulation 2001;103:1832-7.
115. Ordonez-Llanos JS-B. Risk stratification of chest pain patients by point-of-care cardiac troponin T and myoglobin measured in the emergency department. Clin Chim Acta 2006;365:93-7.
116. Ponitz VB-A. Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome. Blood Coagul Fibrinolysis 2009;20:652-60.
117. Sonel A, Sasseen BM, Fineberg N, Bang N, Wilensky RL, Sonel A, et al. Prospective study correlating fbrinopeptide A, troponin I, myoglobin, and myosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain. Circulation 2000;102:1107-13.
118. Svensson L, Axelsson C, Nordlander R, Herlitz J, Svensson L, Axelsson C, et al. Prognostic value of biochemical markers, 12-lead ECG and patient characteristics amongst patients calling for an ambulance due to a suspected acute coronary syndrome. J Intern Med 2004;255:469-77.
119. Szymanski FM, Grabowski M, Filipiak KJ, Karpinski G, Hrynkiewicz A, Stolarz P, et al. Prognostic implications of myocardial necrosis triad markers' concentration measured at admission in patients with suspected acute coronary syndrome. Am J Emerg Med 2007;25:65-8.
120. van Domburg RT, Cobbaert C, Kimman GJ, Zerback R, Simoons ML, van Domburg RT, et al. Long- term prognostic value of serial troponin T bedside tests in patients with acute coronary syndromes. Am J Cardiol 2000;86:623-7.
121. Viswanathan K, Kilcullen N, Morrell C, Thistlethwaite SJ, Sivananthan MU, Hassan TB, et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol 2010;55:2590-8.
122. Yamashita T, Seino Y, Ogawa A, Ogata K, Fukushima M, Tanaka K, et al. N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency. J Cardiol 2010;55:377-83.
123. Casciani E, Polettini E, Bertini L, Rotolo F, Truscelli G, Pittalis A, et al. 16-MDCT angiography coronary artery in the emergency department for patients with acute coronary syndrome (NSTEMI-UA). Clin Ter 2008;159:5-12.
124. Coles DRW. Multislice computed tomography coronary angiography in patients admitted with a suspected acute coronary syndrome. Int J Cardiovasc Imag 2007;23:603-14.
125. Ghersin E, Litmanovich D. 16-MDCT coronary angiography versus invasive coronary angiography in acute chest pain syndrome: a blinded prospective study. AJR Am J Roentgenol 2006;186:177-84.
126. Henneman MM, Schuijf JD, Pundziute G, van Werkhoven JM, van der Wall EE, Jukema JW, et al. Noninvasive evaluation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score. J Am Coll Cardiol 2008;52:216-22.
127. Minocha G, Khurana P, Minocha VA, Manocha S, Srivastava S, Agarwal P, et al. Diagnostic accuracy of multislice CT coronary angiography in patients presenting with non diagnostic chest pain. J Am Coll Cardiol 2006;47:127A.
128. Olivetti L, Mazza G, Volpi D, Costa F, Ferrari O, Pirelli S. Multislice CT in emergency room management of patients with chest pain and medium-low probability of acute coronary syndrome. Radiol Med 2006;111:1054-63.
129. Sato Y, Matsumoto N, Ichikawa M, Kunimasa T, Iida K, Yoda S, et al. Efficacy of multislice computed tomography for the detection of acute coronary syndrome in the emergency department. Circ J 2005;69:1047-51.
130. Tsai IC, Lee T, Lee WL, Tsao CR, Tsai WL, Chen MC, et al. Use of 40-detector row computed tomography before catheter coronary angiography to select early conservative versus early invasive treatment for patients with low-risk acute coronary syndrome. J Comput Assist Tomogr 2007;31:258-64.
131. Goldstein JAG. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol 2007;49:863-71.
132. Hollander JE, Chang AM, Shofer FS, McCusker CM, Baxt WG, Litt HI. Coronary computed tomographic angiography for rapid discharge of low-risk patients with potential acute coronary syndromes. Ann Emerg Med 2009;53:295-304.
133. Hollander JE, Chang AM, Shofer FS, Collin MJ, Walsh KM, McCusker CM, et al. One-year outcomes following coronary computerized tomographic angiography for evaluation of emergency department patients with potential acute coronary syndrome. Acad Emerg Med 2009;16:693-8.
134. Miller AH, Pepe PE, Peshok R, Bhore R, Yancy C Y, Xuan L, et al. Is Coronary Computed Tomography Angiography a Resource Sparing Strategy in the Risk Stratification and Evaluation of Acute Chest Pain? Results of a Randomized Controlled Trial. Acad Emerg Med 2011;18:458-67.
135. Rubinshtein R, Halon DA, Gaspar T, Jaffe R, Karkabi B, Flugelman M Y, et al. Usefulness of 64-slice cardiac computed tomographic angiography for diagnosing acute coronary syndromes and predicting clinical outcome in emergency department patients with chest pain of uncertain origin. Circulation 2007;115:1762-8.
136. Schlett CL, Banerji D, Siegel E, Bamberg F, Lehman SJ, Brady TJ, et al. Prognostic value of CT angiography for major adverse cardiac events in patients with acute chest pain from the emergency department: 2-year outcomes of the ROMICAT trial. J Am Coll Cardiol Cardiovasc Imag 2011;4:481-91.
137. Shuman W P, May JM, Branch KR, Mitsumori LM, Strote JN, Green DE, et al. Negative ECG-gated cardiac CT in patients with low-to-moderate risk chest pain in the emergency department: 1-year follow-up. AJR Am J Roentgenol 2010;195:923-7.
138. Amsterdam EA, Kirk JD, Diercks DB, Lewis WR, Turnipseed SD. Immediate exercise testing to evaluate low-risk patients presenting to the emergency department with chest pain. J Am Coll Cardiol 2002;40:251-6.
139. deFilippi CR, Rosanio S, Tocchi M, Parmar RJ, Potter MA, Uretsky B F, et al. Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain unit: in-hospital and long-term outcomes. J Am Coll Cardiol 2001;37:2042-9.
140. Diercks DB, Gibler B, Liu T, Sayre MR, Storrow AB. Identification of patients at risk by graded exercise testing in an emergency department chest pain center. Am J Cardiol 2000;86:289-92.
141. Gomez MA, Anderson JL, Karagounis LA, Muhlestein JB, Mooers FB. An emergency department- based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study. J Am Coll Cardiol 1996;28:25-33.
142. Goodacre S, Locker T, Arnold J, Angelini K, Morris F. Which diagnostic tests are most useful in a chest pain unit protocol. BMC Emerg Med 2005:5:6.
143. Jeetley P, Burden L, Senior R. Stress echocardiography is superior to exercise ECG in the risk stratification of patients presenting with acute chest pain with negative Troponin. Eur J Echocardiogr 2006;7:155-64.
144. Kerns JR, Shaub T F. Emergency cardiac stress testing in the evaluation of emergency department patients with atypical chest pain. Ann Emerg Med 1993;22:794-8.
145. Kirk JD, Turnipseed S, Lewis WR, Amsterdam EA. Evaluation of chest pain in low-risk patients presenting to the emergency department: the role of immediate exercise testing. Ann Emerg Med 1998;32:1-7.
146. Lewis WR, Amsterdam EA. Utility and safety of immediate exercise testing of low-risk patients admitted to the hospital for suspected acute myocardial infarction. Am J Cardiol 1994; 74:987-90.
147. Polananczyk CA, Johnson PA, Hartley LH, Walls RM, Shaykevich S, Lee TH. Clinical correlates and prognostic significance of early negative exercise tolerance test in patients with acute chest pain seen in the hospital emergency department. Am J Cardiol 1998;81:288-92.
148. Ramakrishna G, Milavetz JJ, Zinmeister AR, Farkouh ME, Evans RW, Allison TG, et al. Effect of exercise treadmill testing and stress imaging on the triage of patients with chest pain. Mayo Clin Proc 2005;80:322-9.
149. Sarullo FM, Di Pasquale P, Orlando G, Buffa G, Cicero S, Schillaci AM. Utility and safety of immediate exercise testing of low-risk patients admitted to hospital with acute chest pain. Int J Cardiol 2000;75:239-43.
150. Tsakonis JS, Shesser R, Rosenthal R, Bittar GD, Smith M, Wasserman AG. Safety of immediate treadmill testing in selected emergency department patients with chest pain: A preliminary report. Am J Emerg Med 1991;9:557-9.
151. Laudon DA, Behrenbeck TR, Wood CM, Bailey KR, Callahan CM, Breen J F, et al. Computed tomographic coronary artery calcium assessment for evaluating chest pain in the emergency department: long-term outcome of a prospective blind study. Mayo Clinic Proc 2010;85:314-22.
152. Goldman L, Cook EF, Brand DA, Lee TH, Rouan GW, Weisberg MC, et al. A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med 1988;318:797-803.
153. Goodacre SW, Bradburn M, Cross E, Collinson PO, Gray A, Hall AS. The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart 2011;97:190-6.
154. Keller T, Zeller T, Ojeda FM, Tzikas S, Lillpopp L, Sinning CR, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-93.
155. Mills NL. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-16.
156. Polanczyk CA, Kuntz KM, Sacks DB, Johnson PA, Lee TH. Emergency department triage strategies for acute chest pain using creatine kinase-MB and troponin I assays: a cost-effectiveness analysis. Ann Intern Med 1999;131:909-18.
157. Ward S, Lloyd JM, Pandor A, Holmes M, Ara R, Ryan A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 2007;11(14).
158. Offce for National Statistics (ONS). Interim Life Tables 2006-08. London: ONS; 2008.
159. Ara R, Brazier J. Health related quality of life by age, gender or history of cardiovascular disease: results from the Health Survey for England (2003 and 2006). Discussion paper 09/12. Sheffeld: University of Sheffeld; 2009.
160. Fitzgerald P, Goodacre SW, Cross E, Dixon S. Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel assay of cardiac markers (RATPAC) Trial. Acad Emerg Med 2011;18:488-95.
161. Department of Health (DoH). Tariff information: confirmation of payment by results (PbR) arrangements for 2009-10. London: DoH; 2011.
162. Stuart RJ, Jr, Ellestad MH. National survey of exercise stress testing facilities. Chest 1980;77:94-7.
163. Stein SC, Hurst RW, Sonnad SS. Meta-analysis of cranial CT scans in children. A mathematical model to predict radiation-induced tumors. Pediatr Neurosurg 2011:44:448-57.
164. Shehadi WH. Adverse reactions to intravascularly administered contrast media. A comprehensive study based on a prospective survey. Am J Roentgenol Radium Ther Nucl Med 1975;124:145-52.
165. Cashman JD, McCredie J, Henry DA. Intravenous contrast media: use and associated mortality. Med J Aust 1991;155:618-23.
166. Johnson LW, Krone R. Cardiac catheterization 1991: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Cathet Cardiovasc Diagn 1993;28:219-20.
167. Atthappan G, Habib M, Ponniah T, Jeyaseelan L. Multi-detector computerized tomography angiography for evaluation of acute chest pain: a meta analysis and systematic review of literature. Int J Cardiol 2010;141;132-40.
168. Savino G, Herzog C, Costello P, Schoepf UJ. 64 slice cardiovascular CT in the Emergency Department: concepts and frst experiences. Emerg Radiol 2006;111:481-96.
169. Gallagher MJ, Ross MA, Raff GL, Goldstein JA, O'Neill WW, O'Neil B. The diagnostic accuracy of 64-slice computed tomography coronary angiography compared with stress nuclear imaging in emergency department low-risk chest pain patients. Ann Emerg Med 2007;49:125-36.
170. Hoffmann U, Nagurney JT, Moselewski F, Pena A, Ferencik M, Chae CU, et al. Coronary multidetector computed tomography in the assessment of patients with acute chest pain. Circulation 2006;114:2251-60.
171. White CS, Kuo D, Keleman M, Jain V, Musk A, Zaidi E, et al. Chest pain evaluation in the emergency department: can MDCT provide a comprehensive evaluation? AJR Am J Roentgenol 2005;185:533-40.
172. Rubinshtein R, Halon DA, Gaspar T, Schliamser JE, Yaniv N, Ammar R, et al. Usefulness of 64-slice multidetector computed tomography in diagnostic triage of patients with chest pain and negative or nondiagnostic exercise treadmill test result. Am J Cardiol 2007;99:925-9.
173. Meijboom WB, van Mieghem CAG, Mollet NR, Pugliese F, Weustinck AC, van Pelt N, et al. 64-slice computed tomography coronary angiography in patients with high, intermediate, or low pretest probability of significant coron artery disease. J Am Coll Cardiol 2007;50:1469-75.
174. Hulten EA, Carbonaro S, Petrillo S P, Mitchell JD, Villines TC. Prognostic value of cardiac computed tomography angiography: a systematic review and meta-analysis. J Am Coll Cardiol 2011;57:1237-47.
175. National Institute for Clinical Excellence (NICE). Guide to the methods of technology appraisals. London: NICE; 2008. URL: www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf.